• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码RNA在骨肉瘤的调控、诊断、预后及治疗中的作用(综述)

The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).

作者信息

Yang Gu, Wu Yanjiao, Wan Rongxue, Sang Hongxun, Liu Huan, Huang Wenhua

机构信息

Guangdong Innovation Platform for Translation of 3D Printing Application, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510000, P.R. China.

Shunde Hospital, Southern Medical University (The First People's Hospital of Shun de), Foshan, Guangdong 528000, P.R. China.

出版信息

Int J Oncol. 2021 Sep;59(3). doi: 10.3892/ijo.2021.5249. Epub 2021 Jul 23.

DOI:10.3892/ijo.2021.5249
PMID:34296296
Abstract

Osteosarcoma (OS) is the most common primary bone tumor worldwide. OS exhibits a range of aggressive behaviors, including early metastasis potential, rapid progression, poor clinical prognosis and insensitivity to chemoradiotherapy. Non‑coding RNAs are transcripts that do not encode proteins. A significant number of studies published on OS have been focused on the aberrant expression of non‑coding RNAs and their involvement in tumor initiation and progression. It has been confirmed that non‑coding RNAs exert their regulatory functions at both the transcriptional and post‑transcriptional level, which leads to tumor initiation or progression in OS. According to present knowledge, this review provides a state‑of‑the‑art overview of the functions and mechanisms of microRNAs, long non‑coding RNAs and circular RNAs in terms of their involvement with OS. The review also covers their potential clinical application in the diagnosis, prognosis and treatment of OS. It is hoped that the information presented in this review on the involvement of non‑coding RNAs in OS will lead to a more comprehensive understanding of OS and provide a useful perspective on the potential diagnostic and therapeutic applications of non‑coding RNAs for patients with OS.

摘要

骨肉瘤(OS)是全球最常见的原发性骨肿瘤。骨肉瘤表现出一系列侵袭性行为,包括早期转移潜能、快速进展、临床预后差以及对放化疗不敏感。非编码RNA是不编码蛋白质的转录本。大量关于骨肉瘤的研究聚焦于非编码RNA的异常表达及其在肿瘤发生和进展中的作用。已经证实,非编码RNA在转录和转录后水平发挥其调控功能,这导致了骨肉瘤的肿瘤发生或进展。根据目前的知识,本综述对微小RNA、长链非编码RNA和环状RNA在骨肉瘤中的功能和机制进行了最新概述。该综述还涵盖了它们在骨肉瘤诊断、预后和治疗方面的潜在临床应用。希望本综述中关于非编码RNA在骨肉瘤中的作用的信息能使人们对骨肉瘤有更全面的了解,并为非编码RNA在骨肉瘤患者潜在诊断和治疗应用方面提供有用的视角。

相似文献

1
The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).非编码RNA在骨肉瘤的调控、诊断、预后及治疗中的作用(综述)
Int J Oncol. 2021 Sep;59(3). doi: 10.3892/ijo.2021.5249. Epub 2021 Jul 23.
2
Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics.靶向骨肉瘤中的 Wnt/β-连环蛋白级联反应:ncRNAs 作为生物标志物和治疗靶点的潜力。
Pathol Res Pract. 2024 Jul;259:155346. doi: 10.1016/j.prp.2024.155346. Epub 2024 May 11.
3
Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA.解析骨肉瘤的化疗耐药性:通过非编码 RNA 的视角揭示调控机制和功能。
Drug Dev Res. 2024 Apr;85(2):e22167. doi: 10.1002/ddr.22167.
4
Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma.lncRNA、circRNA 和 microRNA 网络在调控骨肉瘤铁死亡中的作用研究进展。
Biomed Pharmacother. 2024 Jul;176:116924. doi: 10.1016/j.biopha.2024.116924. Epub 2024 Jun 14.
5
Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.非编码 RNA 在骨肉瘤发病机制、诊断和预后中的新兴作用。
Invest New Drugs. 2018 Dec;36(6):1116-1132. doi: 10.1007/s10637-018-0624-7. Epub 2018 Aug 6.
6
Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells.长链非编码 RNA MALAT1 通过诱饵 miR-140-5p 调控 HDAC4 介导的骨肉瘤细胞增殖和凋亡。
Cancer Med. 2018 Sep;7(9):4584-4597. doi: 10.1002/cam4.1677. Epub 2018 Aug 9.
7
Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.骨肿瘤中与血管生成拟态相关的长非编码 RNA 的表达谱分析。
J Cell Biochem. 2019 Aug;120(8):12473-12488. doi: 10.1002/jcb.28514. Epub 2019 Mar 1.
8
Alteration in the Expression of Circular Rnas and its association with the Development and Progression of Osteosarcoma, an Integrative Review with High Sensitivity Research.环状 RNA 表达的改变及其与骨肉瘤发生发展的关系:一项高灵敏度研究的综合综述。
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1195-1203. doi: 10.31557/APJCP.2024.25.4.1195.
9
Noncoding RNAs as circulating biomarkers in osteosarcoma patients.非编码 RNA 作为骨肉瘤患者的循环生物标志物。
J Cell Physiol. 2019 Nov;234(11):19249-19255. doi: 10.1002/jcp.28744. Epub 2019 Apr 29.
10
Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.长链非编码 RNA CRNDE 作为骨肉瘤的诊断和预后生物标志物发挥作用,并且通过抑制 miR-335-3p 促进其进展。
J Biochem Mol Toxicol. 2021 May;35(5):e22734. doi: 10.1002/jbt.22734. Epub 2021 Feb 1.

引用本文的文献

1
SNX10 in autosomal recessive osteosclerosis, osteosarcoma, rheumatoid arthritis, and osteoporosis: molecular mechanisms and therapeutic implications.常染色体隐性骨硬化症、骨肉瘤、类风湿性关节炎和骨质疏松症中的分选连接蛋白10:分子机制及治疗意义
Front Cell Dev Biol. 2025 Jun 10;13:1602240. doi: 10.3389/fcell.2025.1602240. eCollection 2025.
2
Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma.非编码RNA在外泌体中在骨肉瘤诊断和治疗中的作用。
Front Oncol. 2024 Oct 24;14:1469833. doi: 10.3389/fonc.2024.1469833. eCollection 2024.
3
MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1.
miR-605-3p 通过负向调控 RAF1 抑制骨肉瘤细胞的生长和化疗耐药性。
Protein Pept Lett. 2024;31(7):559-568. doi: 10.2174/0109298665314658240712051206.
4
Sirtuins in intervertebral disc degeneration: current understanding.Sirtuins 在椎间盘退变中的作用:研究现状。
Mol Med. 2024 Mar 29;30(1):44. doi: 10.1186/s10020-024-00811-0.
5
Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research.骨肉瘤研究中非编码RNA的智能结构预测与可视化分析
Front Oncol. 2024 Mar 12;14:1255061. doi: 10.3389/fonc.2024.1255061. eCollection 2024.
6
METTL3-mediated m6A modification of circRNF220 modulates miR-330-5p/survivin axis to promote osteosarcoma progression.METTL3 介导的 circRNF220 的 m6A 修饰调节 miR-330-5p/survivin 轴促进骨肉瘤进展。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17347-17360. doi: 10.1007/s00432-023-05455-x. Epub 2023 Oct 14.
7
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies.骨肉瘤中信号通路的靶向治疗:机制与临床研究
MedComm (2020). 2023 Jul 10;4(4):e308. doi: 10.1002/mco2.308. eCollection 2023 Aug.
8
EPB41L4A-AS1 and UNC5B-AS1 have diagnostic and prognostic significance in osteosarcoma.EPB41L4A-AS1 和 UNC5B-AS1 在骨肉瘤中具有诊断和预后意义。
J Orthop Surg Res. 2023 Mar 30;18(1):261. doi: 10.1186/s13018-023-03754-0.
9
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization.VIM-AS1 通过 IGF2BP2 介导的 HMGCS1 mRNA 稳定促进前列腺癌的增殖并导致恩杂鲁胺耐药。
Int J Oncol. 2023 Mar;62(3). doi: 10.3892/ijo.2023.5482. Epub 2023 Feb 3.
10
PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells.PROSER2是骨肉瘤患者预后不良的生物标志物,可促进骨肉瘤细胞的增殖、迁移和侵袭。
Exp Ther Med. 2022 Nov 8;24(6):750. doi: 10.3892/etm.2022.11686. eCollection 2022 Dec.